Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Bariatric surgery can improve some skin issues but may worsen others due to nutritional deficiencies.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Leucine levels may affect hair loss after bariatric surgery.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Alopecia areata deeply affects self-esteem and identity, needing both medical and emotional support.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib may help people with long-term alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib significantly regrows hair in severe alopecia areata patients.